Cargando…
The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
The dense tumor stroma of pancreatic ductal adenocarcinoma (PDAC) and its secreted immune active molecules provide a barrier for chemotherapy treatment as well as for immune cell infiltration to the tumor core, providing a challenge for immunotherapeutic strategies. Consequently, the investigation o...
Autores principales: | Geyer, Marlene, Gaul, Lisa-Marie, D`Agosto, Sabrina Luigia, Corbo, Vincenzo, Queiroz, Karla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185841/ https://www.ncbi.nlm.nih.gov/pubmed/37205118 http://dx.doi.org/10.3389/fimmu.2023.1155085 |
Ejemplares similares
-
A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment
por: Geyer, Marlene, et al.
Publicado: (2023) -
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study
por: Nicosia, Luca, et al.
Publicado: (2020) -
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
por: Malinova, Antonia, et al.
Publicado: (2021) -
Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma
por: Jaworek, Christian, et al.
Publicado: (2021) -
Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC
por: Strell, Carina, et al.
Publicado: (2017)